AptaBio Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in AptaBio Therapeutics?

AptaBio Therapeutics has 9 investors including Samsung Securities And Midas Doang-A Investment.

Q: How much funding has AptaBio Therapeutics raised to date?

AptaBio Therapeutics has raised obfuscated.

Overview

AptaBio Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About AptaBio Therapeutics

CB Rank

77198

AptaBio Therapeutics is a pharmaceutical biotechnology company that develops intractable innovative drugs.

Founded

obfuscation

Private

Series B

Giheung, Kyonggi-do, South Korea

11-50

www.aptabio.com

Biotechnology

Health Care

Medical

Pharmaceutical

Funding Rounds

Series B

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

AptaBio Therapeutics, Inc.

Also Known As

압타바이오

Operating Status

Active

Company Type

For Profit

Phone Number

+82 31-365-3693

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Oxidative Stress Modulation Platform

A technology platform that regulates oxidative stress to aid in developing treatments for inflammation, fibrosis, diabetic complications, vascular diseases, neurodegenerative diseases, and refractory cancers.

CAF (Cancer-Associated Fibroblast) Regulation Platform

A platform technology that modulates cancer-associated fibroblasts to improve immune checkpoint inhibitor response rates and overcome resistance in refractory cancers.

Research & Development

AptaBio Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - AptaBio Therapeutics	6	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Samsung Securities	—	Series B - AptaBio Therapeutics	—
Samsung Securities	—	Series B - AptaBio Therapeutics	—
Samsung Securities	—	Series B - AptaBio Therapeutics	—
Samsung Securities	—	Series B - AptaBio Therapeutics	—
Samsung Securities	—	Series B - AptaBio Therapeutics	—